Home 禄 Metro 禄 Health and Science
Scientists develop infertility treatment
By Liang Yiwen |
August 17, 2012, Friday
|
Print Edition
Print Edition
LOCAL scientists have developed a micro-pulse hormone infusion system to treat infertility caused by undeveloped secondary sex characteristics.
About 10 million patients in China have this problem. It is caused by two missing hormones - follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones trigger the development and maturation of egg cells in women and sperm in men.
Men diagnosed with the disease idiopathic hypogonadotropic hypogonadism, or IHH, have a low sperm count while female patients with the disease do not ovulate or menstruate.
Shanghai Ruijin Hospital doctors and MicroPort Medical Co Ltd have collaborated to develop a pulse pump that releases the hormone GnRH in pulses or short bursts, usually at 90 to 120 minute intervals.
The release can stimulate the pituitary gland to excrete FSH and LH hormones.
About 10 million patients in China have this problem. It is caused by two missing hormones - follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones trigger the development and maturation of egg cells in women and sperm in men.
Men diagnosed with the disease idiopathic hypogonadotropic hypogonadism, or IHH, have a low sperm count while female patients with the disease do not ovulate or menstruate.
Shanghai Ruijin Hospital doctors and MicroPort Medical Co Ltd have collaborated to develop a pulse pump that releases the hormone GnRH in pulses or short bursts, usually at 90 to 120 minute intervals.
The release can stimulate the pituitary gland to excrete FSH and LH hormones.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
